Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
20 hedge funds and large institutions have $9.23M invested in Innovator IBD ETF Leaders ETF in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, reducing their positions, and closing their positions.
506% more capital invested
Capital invested by funds: $1.52M → $9.23M (+$7.7M)
300% more funds holding
Funds holding: 5 → 20 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$1.59M |
| 2 |
LPL Financial
San Diego,
California
|
+$1.32M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.14M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$785K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$572K |
Top Sellers
LDRS Hedge Fund Activity: Q1 2018 in Review
20 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2018, worth a combined $9.23M — up 506% from $1.52M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new LDRS positions and 0 closed out — a net gain of 15 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Financial Advocates Investment Management, adding an estimated $1.59M.
- 20 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2018, up from 5 in Q4 2017.
- Funds reported $9.23M of Innovator IBD ETF Leaders ETF stock for Q1 2018, up 506% quarter-over-quarter.
- 15 funds opened new Innovator IBD ETF Leaders ETF positions in Q1 2018 and 0 closed out, a net change of +15 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q1 2018 was Financial Advocates Investment Management, an estimated $1.59M added.
Based on aggregated 13F filings for Q1 2018.